JP Morgan names 2 stock categories facing the biggest threat

JPMorgan warned that rising 30-year government bond yields, increasingly linked to fiscal risks and debt supply, are pressuring small- and mid-cap valuations, financing costs and relative appeal versus bonds. The share of US small- and mid-cap stocks yielding more than the 30-year Treasury fell from 19% at the start of 2024 to 9%, a 24-year low; the 30-year Treasury–fed funds rate gap widened to 1.42% from 0.73%. JPMorgan nevertheless identified selected opportunities, adding Dashenlin Pharmaceutical Group (about $3 billion) and Befesa (about €1.4 billion) to its model portfolio, both Overweight.

Analysis

The key risk is a breakdown in the usual “Fed cuts = lower discount rates” trade: if fiscal supply and term premium dominate, long yields can stay elevated even as short rates fall. That would pressure small-cap valuations and refinancing economics, while making a dividend-yield screen less reliable as a safety signal. The potential second-order effect is multiple compression across domestically exposed, externally financed companies—not just weaker demand for their shares.

Near term (days to weeks), Treasury auction demand and fiscal headlines matter more than a single Fed communication. Over 1–3 months, watch whether the 30-year yield and term premium keep rising despite softer growth or easing short rates; that would confirm a fiscal-risk regime. Over 6–18 months, sustained high long rates could defer capex and refinancing, widening performance dispersion between balance-sheet-strong small caps and leveraged firms.

The contrarian point: the dividend-yield comparison is not a valuation floor. A high yield can reflect expected earnings stress or a prospective cut, and the screening rule may miss companies with low payout ratios but stronger balance sheets. Befesa (BFSA) is a possible stock-specific watch, not an automatic beneficiary of the model-portfolio inclusion: verify dividend coverage, net debt, and sensitivity to industrial activity and input costs before underwriting the yield. The thesis weakens if long yields retreat as fiscal concerns ease, or if small-cap earnings and guidance remain resilient despite tighter financial conditions.

Key Decisions for Investors

• Consider a beta-adjusted short IWM / long SPY relative-value position only if long-end yields continue rising while short-rate expectations fall; scale in rather than trade the headline. Falsify on a sustained reversal in the 30-year yield/term premium or improving small-cap earnings breadth. Set actual levels from current market data; none are provided here.
• Avoid treating high dividend yield versus the 30-year Treasury as a standalone buy signal. Screen small- and mid-cap holdings for refinancing needs, floating-rate exposure, payout coverage, and near-term maturities; favor balance-sheet resilience over headline yield.
• Keep BFSA on a diligence watchlist rather than initiating solely on the cited Overweight rating. Verify current valuation, dividend coverage, leverage, and exposure to industrial demand and input costs; reassess if financial statements or guidance show the yield is not covered.
• Track Treasury auction demand, fiscal-policy developments, and the 30-year yield/term premium over the next 1–3 months. A fiscal-risk premium that persists through weaker growth data would argue against assuming Fed easing will rescue long-duration small-cap valuations.